BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31532582)

  • 21. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.
    Jarienė K; Vaitkienė D; Bartusevičius A; Tvarijonavičienė E; Minkauskienė M; Nadišauskienė R; Kruminis V; Kliučinskas M
    Medicina (Kaunas); 2012; 48(1):22-30. PubMed ID: 22481371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
    Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
    Chatzistamatiou K; Moysiadis T; Moschaki V; Panteleris N; Agorastos T
    Gynecol Oncol; 2016 Jul; 142(1):120-127. PubMed ID: 27126005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.
    Zhao C; Chen X; Onisko A; Kanbour A; Austin RM
    Gynecol Oncol; 2011 Aug; 122(2):291-6. PubMed ID: 21601911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of human papillomavirus testing and endocervical component on pap tests: A pilot study using the Roche Cobas(®) assay.
    Pierce KJ; Currens HS; Tafe LJ; Tsongalis GJ; Padmanabhan V
    Diagn Cytopathol; 2016 Apr; 44(4):280-2. PubMed ID: 26801205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
    Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
    Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical squamous cells of undetermined significance cervical cytology in the Chinese population: Age-stratified reporting rates, high-risk HPV testing, and immediate histologic correlation results.
    Tao X; Zhang H; Wang L; Pan Q; Ji S; Zhou X; Zhao C
    Cancer Cytopathol; 2021 Jan; 129(1):24-32. PubMed ID: 32697438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Eckert K; Kodsi S; Cooper C
    Am J Clin Pathol; 2019 Mar; 151(4):433-442. PubMed ID: 30649177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study.
    Stoler MH; Wright TC; Sharma A; Zhang G; Apple R; Wright TL; Behrens CM;
    Am J Clin Pathol; 2012 Feb; 137(2):295-303. PubMed ID: 22261457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
    Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
    Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall.
    Chiappetta C; Puggioni C; Lendaro E; Cacciotti J; Zaralli R; Migliore G; Bellardini P; Petrozza V; Della Rocca C; Di Cristofano C
    Int J Clin Exp Pathol; 2015; 8(12):16089-96. PubMed ID: 26884886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of human papillomavirus typization and cytology in early detection of relapse of cervical intraepithelial neoplasia].
    Zivadinović R; Lilić V; Djordjević B; Stanojević Z; Petrić A; Lilić G
    Vojnosanit Pregl; 2011 Apr; 68(4):314-20. PubMed ID: 21630519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
    Pajtler M; Milicić-Juhas V; Milojković M; Topolovec Z; Curzik D; Mihaljević I
    Coll Antropol; 2010 Mar; 34(1):81-6. PubMed ID: 20432737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.